The cost of insulin has surged dramatically over the past decades, burdening patients who rely on this life-saving medication. Rising costs have drawn scrutiny from regulators, lawmakers, and consumers, leading to investigations into the pharmaceutical industry's pricing mechanisms. Among the
The healthcare industry witnessed a significant move today as Boston Scientific announced the completion of its acquisition of Silk Road Medical. This transaction, valued at $1.28 billion, represents a strategic milestone for Boston Scientific, aiming to enhance their technological prowess in the
The healthcare sector is continuously evolving, but along with these advancements come increased vulnerabilities to cyber threats. Cyber resilience has thus become paramount. This article explores the dynamic landscape of cyber resilience in the healthcare industry, the key challenges, and the
Amid rising concerns over national security and economic self-reliance, the U.S. Congress has introduced the BIOSECURE Act. Aimed at curbing Chinese influence in the biotechnology sector, this legislation prevents companies with Chinese ties from accessing federal funding. While the Act promises
The call for legislative intervention to overturn the FDA's final rule on the regulation of laboratory-developed tests (LDTs) has intensified. The Association for Diagnostics and Laboratory Medicine (ADLM) has been at the forefront, urging lawmakers to take action against the FDA's new rule. This
The Biden administration has taken a remarkable step forward in mental health care by finalizing rules that expand mental health coverage standards in private insurance plans. This bold move aims to address the longstanding disparities between mental and physical health benefits, ensuring millions
